Abstract:The relationship between a drug and its target directly affects its pharmacology and efficacy. Drug-target binding ability and binding stoichiometry are essential characterization data in pharmaceutical research. The c-myb proto-oncogene encodes a crucial transcription factor that is involved in proliferation, differentiation, and maturation during hematopoiesis. Recent studies have found that the human oncogene c-myb is overexpressed in cancer tissues such as colorectal cancer. C-myb has become a potential therapeutic target for colorectal cancer, leukemia, and other cancers. A guanine (G)-rich DNA sequence located in the promoter region of c-myb can be spontaneously folded to form an intra-molecular G-quadruplex (G4) with cationic induction. The specific recognition of small molecules can stabilize this G4 folding, thus regulating the transcription and expression of c-myb. In this study, pressure assisted capillary electrophoresis frontier analysis (PACE-FA) combined with electrospray ionization mass spectrometry (ESI-MS) was used to investigate the interactions between the human c-myb promoter G4 and natural product molecules. In PACE-FA, an external pressure (no more than 13.8 kPa) in the same direction of the migration of the analyte was used in capillary electrophoresis frontier analysis (CE-FA), which greatly sped up the analysis while maintaining the accuracy of the results. Meanwhile, the combination of PACE-FA and ESI-MS could rapidly determine the affinity and stoichiometric relationship between binding molecules and targets. First, the intramolecular parallel-stranded G4 formation of the c-myb promoter sequence in the presence of cations (K+, NH4+) was investigated by circular dichroism (CD) and ESI-MS. Then, ESI-MS was used to rapidly screen the natural products for candidate molecules that bound the target G4 DNA. The binding interactions were measured by mixing the c-myb DNA with each natural product separately in a 1:4 molar ratio, and then directly infusing these mixtures into the ESI-MS system. From the ESI-MS spectra, IRa values calculated from the relative intensities of DNA and its complex ions were used to probe the binding affinities of the natural products. This parameter denotes the relative binding affinity for a small molecule with the G4 DNA. Three natural products were identified through the screen, and their binding affinities to G4 DNA were ranked as follows:pseudolaric acid B > scopolamine butylbromide > nuciferine. Considering that both specific and non-specific binding existed in the solution phase, a free solution method using PACE-FA was developed to further test the binding ability of these products to the c-myb promoter G4 DNA. In the PACE-FA experiments, the pre-equilibrated mixture of the c-myb G4 DNA and the selected ligand was injected into the capillary prior to separation. Upon applying voltage and an external pressure (6.9 kPa) to the capillary, different species of analytes in the sample migrated at their own rates due to their different sizes and charges. The results showed that scopolamine butylbromide could bind specifically to target G4 DNA with 1:1 stoichiometry and a binding constant of 1.18×105 L/mol. Nuciferine's binding to G4 DNA showed a linear increasing trend due to nonspecific binding; thus nuciferine is a nonspecific binder. Although pseudolaric acid B showed high affinity for the c-myb G4 DNA and 1:1 and 1:2 G4-bound complex ions were observed in ESI-MS measurements, the PACE-FA results indicated that pseudolaric acid B did not bind to target G4 DNA in free solution. Therefore, scopolamine butylbromide could be the best candidate to regulate the transcription of the c-myb oncogene, and is expected to be a precursor for anticancer drugs. In this work, PACE-FA has allowed for significant improvements to the conventional CE-FA technique. This combination of PACE-FA and ESI-MS not only reduced the time needed for binding analysis, but also improved the accuracy and specificity of the affinity analysis compared to conventional binding approaches. Furthermore, this combination could be used to screen other targeted drug candidates and to evaluate their interaction mechanisms.

Exploration of Binding Affinity and Selectivity of Brucine with G-quadruplex in the C-Myb Proto-Oncogene by Electrospray Ionization Mass Spectrometry.

Utilization of circular dichroism and electrospray ionization mass spectrometry to understand the formation and conversion of G-quadruplex DNA at the human c-myb proto-oncogene.

[Determination of the Binding of Natural Products to the Human C-Myb Oncogene Promoter G-quadruplex DNA by Capillary Electrophoresis and Electrospray Ionization Mass Spectrometry].

Electrospray ionization mass spectrometric exploration of the high-affinity binding of three natural alkaloids with the mRNA G-quadruplex in the BCL2 5'-untranslated region.

ESI Mass Spectrometric Exploration of Selective Recognition of G-Quadruplex in c - myb Oncogene Promoter Using a Novel Flexible Cyclic Polyamide

Exploration of the Selective Recognition of the G-quadruplex in the N-myc Oncogene by Electrospray Ionization Mass Spectrometry.

Formation and Recognition of G-quadruplex in Promoter of C-Myb Oncogene by Electrospray Ionization Mass Spectrometry.

Exploration of G-quadruplex Function in C-Myb Gene and Its Transcriptional Regulation by Topotecan.

Spectroscopy Probing of the Formation, Recognition, and Conversion of A G-Quadruplex in the Promoter Region of the Bcl-2 Oncogene

Exploration of a Multi-Target Ligand, Dehydroevodiamine, for the Recognition of Three G-quadruplexes in C-Myb Proto-Oncogene by ESI–MS

Electrospray Ionization Mass Spectrometry Probing of Binding Affinity of Berbamine, a Flexible Cyclic Alkaloid from Traditional Chinese Medicine, with G-quadruplex DNA.

Bisquinolinium-fluorescein conjugates as specific fluorescence probes of c-myc Pu22 G-quadruplex and their bioimaging and anticancer activities

A Newly Identified G-quadruplex As a Potential Target Regulating Bcl-2 Expression

Spectroscopic Probing of Recognition of the G-quadruplex in C-Kit Promoter by Small-Molecule Natural Products

Molecular Insights into the Specific Targeting of c-MYC G-Quadruplex by Thiazole Peptides

Investigation on the Formation, Conversion and Bioactivity of A G-Quadruplex Structure in the Palb2 Gene

Discovery of a New Four-Leaf Clover-Like Ligand as a Potent c-MYC Transcription Inhibitor Specifically Targeting the Promoter G-Quadruplex.

Structure of G-Quadruplex in the Oncogene c-myc Promoter and Small Ligands Targeting the G-Quadruplex

Bruceine B Displays Potent Antimyeloma Activity by Inducing the Degradation of the Transcription Factor C-Maf.

Quantitative characterization of human oncogene promoter G-quadruplex DNA-ligand interactions using a combination of mass spectrometry and capillary electrophoresis

Abstract 2756: Custom G4 DNA microarray can determine large-scale binding selectivity of small molecules and proteins to oncogene G-quadruplexes